Rituximab, an anti CD20 monoclonal antibody, is used in the management of lymphoproliferative and autoimmune conditions. This activity reviews the indications, mechanism of action, contraindications, adverse effects, and other key factors (e.g., off-label uses, monitoring) pertinent for the healthcare team members.
Copyright © 2024, StatPearls Publishing LLC.